Skinvisible Web Sign Up for Updates         T 702.433.7154
Skinvisible - Polymer Delivery System

The Ultimate Polymer Delivery System.

Investor Overview

SKVI trading Exclusively on OTCQB

To get a SKVI quote today, click here:

IMPORTANT: The OTCQB inter-dealer quotation system is interlinked with most financial websites but we encourage you to look at other sites if you do not see a current quote. All financial websites should be up-to-date in the near future.

Shareholder's Information:

Shares Outstanding Are: 4,539,843 (as of May 15, 2024)
Authorized Shares: 200,000,000
Fiscal Year End: December 31

SKVI trading Exclusively on OTCQB
stock symbol SKVI

July 9, 2024
Skinvisible Unveils Promising Data on Transdermal Obesity Formulations

June 24, 2024
Skinvisible Expands Obesity Patent Application for Transdermal Delivery

May 29, 2024
Skinvisible Submits Innovative Obesity Patent for Advanced Transdermal Treatment

February 14, 2024
Skinvisible Announces Significant Progress In Licensee's Clinical Trials For Invisicare Formulation Targeting Nethertons Syndrome

More News...

Stock Information:

  SKVI quote
  Press Releases

Sign up for Skinvisible Inc. Updates: Click here to join our mailing list.
Home    |     About us    |    Technology    |    Products    |    Investors    |    Contact Us    |    Disclaimer & Privacy    |     Sign Up for Updates
© 2008 Skinvisible Pharmaceuticals, Inc.     Note: This website is not intended for Canadian residents.